Collegium Pharmaceutical Stock (NASDAQ: COLL) stock price, news, charts, stock research, profile.
Open | $33.010 |
Close | $31.500 |
Volume / Avg. | 2.254M / 418.987K |
Day Range | 30.420 - 34.000 |
52 Wk Range | 20.830 - 40.950 |
Market Cap | $1.145B |
P/E Ratio | 29.380 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 28 |
Short Interest | 26.39% |
Days to Cover | 21.31 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Collegium Pharmaceutical (NASDAQ: COLL) through any online brokerage.
Other companies in Collegium Pharmaceutical’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS) and Phibro Animal Health (NASDAQ:PAHC).
The latest price target for Collegium Pharmaceutical (NASDAQ: COLL) was reported by Needham on Friday, May 10, 2024. The analyst firm set a price target for 0.00 expecting COLL to fall to within 12 months (a possible -100.00% downside). 13 analyst firms have reported ratings in the last year.
The stock price for Collegium Pharmaceutical (NASDAQ: COLL) is $35 last updated May 10, 2024 at 8:00 AM EDT.
There are no upcoming dividends for Collegium Pharmaceutical.
Collegium Pharmaceutical’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Collegium Pharmaceutical.
Collegium Pharmaceutical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.